Your browser doesn't support javascript.
loading
Systematic elucidation and pharmacological targeting of tumor-infiltrating regulatory T cell master regulators.
Obradovic, Aleksandar; Ager, Casey; Turunen, Mikko; Nirschl, Thomas; Khosravi-Maharlooei, Mohsen; Iuga, Alina; Jackson, Christopher M; Yegnasubramanian, Srinivasan; Tomassoni, Lorenzo; Fernandez, Ester Calvo; McCann, Patrick; Rogava, Meri; DeMarzo, Angelo M; Kochel, Christina M; Allaf, Mohamad; Bivalacqua, Trinity; Lim, Michael; Realubit, Ronald; Karan, Charles; Drake, Charles G; Califano, Andrea.
Afiliación
  • Obradovic A; Columbia Center for Translational Immunology, Irving Medical Center, New York, NY, USA; Department of Systems Biology, Columbia University Irving Medical Center, New York, NY, USA.
  • Ager C; Columbia Center for Translational Immunology, Irving Medical Center, New York, NY, USA; Department of Hematology Oncology, Columbia University Irving Medical Center, New York, NY, USA.
  • Turunen M; Department of Systems Biology, Columbia University Irving Medical Center, New York, NY, USA.
  • Nirschl T; Department of Oncology, The Johns Hopkins University School of Medicine, Baltimore, MD, USA.
  • Khosravi-Maharlooei M; Columbia Center for Translational Immunology, Irving Medical Center, New York, NY, USA.
  • Iuga A; Department of Pathology, UNC School of Medicine, Chapel Hill, NC, USA.
  • Jackson CM; Department of Neurosurgery, The Johns Hopkins University School of Medicine, Baltimore, MD, USA.
  • Yegnasubramanian S; Department of Oncology, The Johns Hopkins University School of Medicine, Baltimore, MD, USA.
  • Tomassoni L; Department of Systems Biology, Columbia University Irving Medical Center, New York, NY, USA.
  • Fernandez EC; Department of Systems Biology, Columbia University Irving Medical Center, New York, NY, USA.
  • McCann P; Herbert Irving Comprehensive Cancer Center, Columbia University Irving Medical Center, New York, NY, USA.
  • Rogava M; Herbert Irving Comprehensive Cancer Center, Columbia University Irving Medical Center, New York, NY, USA.
  • DeMarzo AM; Department of Oncology, The Johns Hopkins University School of Medicine, Baltimore, MD, USA; Department of Urology, The Johns Hopkins University School of Medicine, Baltimore, MD, USA; Department of Pathology, The Johns Hopkins University School of Medicine, Baltimore, MD, USA.
  • Kochel CM; Department of Oncology, The Johns Hopkins University School of Medicine, Baltimore, MD, USA.
  • Allaf M; Department of Urology, The Johns Hopkins University School of Medicine, Baltimore, MD, USA.
  • Bivalacqua T; Department of Urology, The Johns Hopkins University School of Medicine, Baltimore, MD, USA.
  • Lim M; Department of Neurosurgery, Stanford School of Medicine, Palo Alto, CA, USA.
  • Realubit R; Department of Systems Biology, Columbia University Irving Medical Center, New York, NY, USA; J.P. Sulzberger Columbia Genome Center, Columbia University, New York, NY, USA; Herbert Irving Comprehensive Cancer Center, Columbia University Irving Medical Center, New York, NY, USA.
  • Karan C; Department of Systems Biology, Columbia University Irving Medical Center, New York, NY, USA; J.P. Sulzberger Columbia Genome Center, Columbia University, New York, NY, USA; Herbert Irving Comprehensive Cancer Center, Columbia University Irving Medical Center, New York, NY, USA.
  • Drake CG; Columbia Center for Translational Immunology, Irving Medical Center, New York, NY, USA; Department of Oncology, The Johns Hopkins University School of Medicine, Baltimore, MD, USA.
  • Califano A; Department of Systems Biology, Columbia University Irving Medical Center, New York, NY, USA; Department of Oncology, The Johns Hopkins University School of Medicine, Baltimore, MD, USA; J.P. Sulzberger Columbia Genome Center, Columbia University, New York, NY, USA; Herbert Irving Comprehensive Cance
Cancer Cell ; 41(5): 933-949.e11, 2023 05 08.
Article en En | MEDLINE | ID: mdl-37116491

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Linfocitos T Reguladores / Neoplasias Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Cancer Cell Asunto de la revista: NEOPLASIAS Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Linfocitos T Reguladores / Neoplasias Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Cancer Cell Asunto de la revista: NEOPLASIAS Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Estados Unidos